Salix Licenses Right to Market and Distribute Sanvar® from Debiopharm
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 76 (Table of Contents)
Published: 6 Oct-2006
DOI: 10.3833/pdr.v2006.i76.450 ISSN: 1756-7874
Section: Distribution & Marketing
Fulltext:
Abstract
Salix Pharmaceuticals and Debiopharm entered into license agreement to sell, market and distribute Salix’s Sanvar® (vapreotide acetate) for treating acute oesophageal variceal bleeding (AOVB)...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS